Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. Supervision of the Conduct of a Clinical Investigation
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. Protecting the Rights, Safety, and Welfare of Study Subjects
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Připravované klinické studie
-
Hoffmann-La RocheChugai PharmaceuticalNáborStředně až těžce aktivní ulcerózní kolitidaSpojené státy
-
Sagimet Biosciences Inc.Zatím nenabírámeNealkoholická steatohepatitida | Nealkoholická ztučnělá játra | NASH | KAŠE | Steatohepatitida spojená s metabolickou dysfunkcí | Steatohepatitida spojená s necirhotickou metabolickou dysfunkcí
-
Senthil SadhasivamEunice Kennedy Shriver National Institute of Child Health and Human Development...Zatím nenabíráme
-
Thomas Jefferson UniversitySidney Kimmel Cancer Center at Thomas Jefferson UniversityZatím nenabíráme
-
Tulane UniversityMichigan State UniversityZatím nenabírámeZastavení vapingu
-
Cairo UniversityNábor
-
University College, LondonRoyal Free Hospital NHS Foundation TrustZatím nenabíráme
-
Second Affiliated Hospital, School of Medicine,...Zatím nenabíráme
-
Shandong Provincial HospitalZatím nenabírámePapilární karcinom štítné žlázy
-
University of Maryland, BaltimoreNáborAkutní myeloidní leukémieSpojené státy
-
Canadian Medical and Surgical Knowledge Translation...NáborKardiovaskulární onemocnění | Onemocnění periferních cév | Cukrovka typu 2 | Onemocnění periferních tepenKanada
-
Canadian Medical and Surgical Knowledge Translation...NáborKardiovaskulární choroby | Dyslipidémie | Ischemická choroba srdeční | Ateroskleróza Kardiovaskulární onemocněníKanada